Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zheqi Li

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Cancer Cell|October 4, 2024
Midkine as a driver of age-related changes and increase in mammary tumorigenesisPengze Yan, Ernesto Rojas Jimenez, Zheqi Li, et al.
Molecular Cancer Research : MCR|March 17, 2023
FOXA1 Reprogramming Dictates Retinoid X Receptor Response in ESR1-Mutant Breast CancerYang Wu, Zheqi Li, Abdalla M Wedn, et al.
Nature Cell Biology|June 26, 2024
Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3Marco Seehawer, Zheqi Li, Jun Nishida, et al.
Cancer Discovery|April 2, 2026
HER2 heterogeneous breast cancer models reveal novel therapeutic targets and subclonal dynamics during evolution to resistance to HER2-targeted therapiesMarie-Anne Goyette, Christopher Graser, Marco Seehawer, et al.
Breast Cancer Research : BCR|May 25, 2017
Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell modelsAmir Bahreini, Zheqi Li, Peilu Wang, et al.
Journal of the American Chemical Society|March 2, 2026
Unraveling the Role of Ionizable Lipid Isomerism in Modulating Lipid Nanoparticles for mRNA DeliveryZepeng He, Zhijia Liu, Taisen Zuo, et al.
Oncology|January 8, 2018
Clinically Observed Estrogen Receptor Alpha Mutations within the Ligand-Binding Domain Confer Distinguishable PhenotypesShanhang Jia, Mark T Miedel, Marilyn Ngo, et al.
Molecular Cancer Therapeutics|September 7, 2023
Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast CancerMaša Alečković, Zheqi Li, Ningxuan Zhou, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
EstroGene2.0: A multi-omic database of response to estrogens, ER-modulators, and resistance to endocrine therapies in breast cancerZheqi Li, Fangyuan Chen, Li Chen, et al.
NPJ Breast Cancer|December 20, 2024
The EstroGene2.0 database for endocrine therapy response and resistance in breast cancerZheqi Li, Fangyuan Chen, Li Chen, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Cancer Cell|October 4, 2024
Midkine as a driver of age-related changes and increase in mammary tumorigenesisPengze Yan, Ernesto Rojas Jimenez, Zheqi Li, et al.
Molecular Cancer Research : MCR|March 17, 2023
FOXA1 Reprogramming Dictates Retinoid X Receptor Response in ESR1-Mutant Breast CancerYang Wu, Zheqi Li, Abdalla M Wedn, et al.
Nature Cell Biology|June 26, 2024
Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3Marco Seehawer, Zheqi Li, Jun Nishida, et al.
Cancer Discovery|April 2, 2026
HER2 heterogeneous breast cancer models reveal novel therapeutic targets and subclonal dynamics during evolution to resistance to HER2-targeted therapiesMarie-Anne Goyette, Christopher Graser, Marco Seehawer, et al.
Breast Cancer Research : BCR|May 25, 2017
Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell modelsAmir Bahreini, Zheqi Li, Peilu Wang, et al.
Journal of the American Chemical Society|March 2, 2026
Unraveling the Role of Ionizable Lipid Isomerism in Modulating Lipid Nanoparticles for mRNA DeliveryZepeng He, Zhijia Liu, Taisen Zuo, et al.
Oncology|January 8, 2018
Clinically Observed Estrogen Receptor Alpha Mutations within the Ligand-Binding Domain Confer Distinguishable PhenotypesShanhang Jia, Mark T Miedel, Marilyn Ngo, et al.
Molecular Cancer Therapeutics|September 7, 2023
Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast CancerMaša Alečković, Zheqi Li, Ningxuan Zhou, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
EstroGene2.0: A multi-omic database of response to estrogens, ER-modulators, and resistance to endocrine therapies in breast cancerZheqi Li, Fangyuan Chen, Li Chen, et al.
NPJ Breast Cancer|December 20, 2024
The EstroGene2.0 database for endocrine therapy response and resistance in breast cancerZheqi Li, Fangyuan Chen, Li Chen, et al.
Pageof 7